School of Medicine
Showing 901-936 of 936 Results
-
Bianxiao Cui
Job and Gertrud Tamaki Professor of Chemistry
On Leave from 01/01/2025 To 03/31/2025Current Research and Scholarly InterestsOur objective is to develop new biophysical methods to advance current understandings of cellular machinery in the complicated environment of living cells. Currently, we are focusing on four research areas: (1) Membrane curvature at the nano-bio interface; (2) Nanoelectrode arrays (NEAs) for scalable intracellular electrophysiology; (3) Electrochromic optical recording (ECORE) for neuroscience; and (4) Optical control of neurotrophin receptor tyrosine kinases.
-
Chuyi Cui, PhD
Postdoctoral Scholar, Neurology and Neurological Sciences
BioDr. Chuyi Cui is a postdoctoral scholar in the Human Motor Control and Neuromodulation Lab at Stanford University School of Medicine. She earned her Ph.D. in Biomechanics and Motor Control, with a minor in Gerontology, from Purdue University. Her doctoral research focused on understanding gait control and stability in healthy aging, through comprehensive investigations of the kinematics and kinetics of adaptive locomotion in young and older adults. At Stanford, her postdoctoral research expanded to clinical populations, aiming to uncover the mechanisms underlying gait dysfunction in neurodegenerative diseases. Under the guidance of Dr. Helen Bronte-Stewart, she contributes to clinical trials on closed-loop deep brain stimulation (DBS) for Parkinson's Disease, utilizing advanced neuromodulation technology to develop and evaluate DBS therapies that adapt in real time to patients' motor fluctuations and alleviate gait symptoms.
-
Hejie Cui
Postdoctoral Scholar, Biomedical Informatics
BioDr. Hejie Cui is a postdoctoral researcher at the Stanford Center for Biomedical Informatics Research at Stanford University. Her research focuses on the intersection of machine learning, data mining, and biomedical informatics. At Stanford, Dr. Cui works on large language model (LLM) evaluation and post-training for healthcare. Dr. Cui has authored and co-authored several publications in top computer science and interdisciplinary venues, including NeurIPS, KDD, AAAI, CIKM, TMI, and MICCAI. Her work contributes to advancing the application of artificial intelligence in healthcare and improving the understanding of complex biomedical data. Dr. Cui was selected as a Rising Star in EECS in 2023. She has also received numerous awards, including the Fellowship of 2021 CRA-WP Grad Cohort for Women, Student Travel Grant Award for MICCAI'22, NSF Travel Grant for CIKM'22, and NeurIPS AI4Science Travel Award for NeurIPS'22. Dr. Cui holds a Ph.D. in Computer Science from Emory University (2024) and a B.Eng. in Computer Science and Engineering from Tongji University (2019). During her graduate studies, she gained industry experience through internships at Microsoft Research and Amazon Science.
-
Arlene S. Cullum, MPH
Recruitment and Engagement, Pediatrics - Neonatology
Current Role at StanfordDirector of Special Projects, Department of Pediatrics, School of Medicine Stanford University
-
Maria Elizabeth Currie, MD, PhD
Clinical Assistant Professor, Cardiothoracic Surgery
BioDr. Currie is a board-certified, fellowship-trained cardiothoracic surgeon. She is also a clinical assistant professor at Stanford University School of Medicine. With subspecialty training in heart failure, Dr. Currie treats all forms of cardiomyopathy, ischemic heart disease, and valvular heart disease. She performs heart transplant, lung transplant, and combined heart-lung transplant procedures as part of a multidisciplinary team. She excels at valve surgery and the implantation of mechanical circulatory support systems.
Dr. Currie welcomes referrals from cardiologists and primary care physicians as early as possible when cardiovascular disease is suspected. Understanding that early intervention can prevent later complications, she invites communication about screening, diagnostics, and treatment strategies.
For each patient, Dr. Currie’s goal is to achieve the best possible outcome using the most advanced minimally invasive cardiac care techniques and technology available. Combined with technical expertise and a focus on excellent clinical outcomes, Dr. Currie delivers empathetic, thoughtful patient care. She ensures that patients are well informed about what they can expect both before and after their surgical procedure.
Dr. Currie is passionate about improving the safety of cardiac surgery. Her research includes translational studies on new ways to visualize anatomic structures that are difficult to see during minimally invasive surgery. One published study investigated the use of augmented reality (AR) guided by transesophageal echocardiography in minimally invasive mitral valve repair. Her work has appeared in The Journal of Thoracic and Cardiovascular Surgery, The Annals of Thoracic Surgery, The International Journal of Medical Robotics and Computer Assisted Surgery, Transplant Immunology, and other peer reviewed publications.
Dr. Currie’s interest in technological advances is rooted in her commitment to the evolution of technology and technique in the fast-changing, relatively young field of cardiac surgery. Also driving her interest is her PhD background in biomedical engineering. She has made presentations on the use of AR systems, 3D visualization technology, and robotics-assisted surgical procedures at the American Association for Thoracic Surgery Annual Meeting, International Society for Minimally Invasive Surgery Annual Scientific Meeting, and other conferences.
Dr. Currie has won numerous awards for her research achievements and scholarship. She is a Fellow of the Royal College of Surgeons of Canada. She is also a member of The Society of Thoracic Surgeons, the International Society for Heart and Lung Transplantation, the International Society for Minimally Invasive Cardiothoracic Surgery, Women in Thoracic Surgery, and the Association of Women Surgeons. With its long legacy of leadership in cardiac surgery and research, Dr. Currie feels Stanford Health Care enables her to pursue her research interests and offers her patients access to the latest innovations, along with expertise across specialties including engineering and statistics. -
Catherine Curtin MD
Professor of Surgery (Plastic & Reconstructive Surgery) and, by courtesy, of Orthopaedic Surgery
Current Research and Scholarly InterestsMaintaining and optimizing upper limb function in people with spinal cord injury and other nerve disorders.
Improving pain and general well being after severe hand injuries.
Improving treatment and recognition of pain. -
Christina Curtis
RZ Cao Professor, Professor of Genetics and of Biomedical Data Science
Current Research and Scholarly InterestsThe Curtis laboratory for Cancer Computational and Systems Biology is focused on the development and application of innovative experimental, computational, and analytical approaches to improve the diagnosis, treatment, and early detection of cancer.
-
Martha S. Cyert
Dr. Nancy Chang Professor
Current Research and Scholarly InterestsThe Cyert lab is identifying signaling networks for calcineurin, the conserved Ca2+/calmodulin-dependent phosphatase, and target of immunosuppressants FK506 and cyclosporin A, in yeast and mammals. Cell biological investigations of target dephosphorylation reveal calcineurin’s many physiological functions. Roles for short linear peptide motifs, or SLiMs, in substrate recognition, network evolution, and regulation of calcineurin activity are being studied.
-
Agnieszka Czechowicz, MD, PhD
Assistant Professor of Pediatrics (Stem Cell Transplantation)
Current Research and Scholarly InterestsDr. Czechowicz’s research is aimed at understanding how hematopoietic stem cells interact with their microenvironment in order to subsequently modulate these interactions to improve bone marrow transplantation and unlock biological secrets that further enable regenerative medicine broadly. This work can be applied across a variety of disease states ranging from rare genetic diseases, autoimmune diseases, solid organ transplantation, microbiome-augmentation and cancer.
